TY - JOUR
T1 - Genetic Variation within a metabolic motif in the chromogranin a promoter
T2 - Pleiotropic influence on cardiometabolic risk traits in twins
AU - Rao, Fangwen
AU - Chiron, Stephane
AU - Wei, Zhiyun
AU - Fung, Maple M.
AU - Chen, Yuqing
AU - Wen, Gen
AU - Khandrika, Srikrishna
AU - Ziegler, Michael G.
AU - Benyamin, Beben
AU - Montgomery, Grant
AU - Whitfield, John B.
AU - Martin, Nicholas G.
AU - Waalen, Jill
AU - Hamilton, Bruce A.
AU - Mahata, Sushil K.
AU - O'Connor, Daniel T.
N1 - Funding Information:
Supplementary material is linked to the online version of the paper at http:// www.nature.com/ajh acknowledgments:This work was supported by the National Institutes of Health and the Department ofVeterans affairs.We appreciate the assistance of the NIH/NCRR-supported General Clinical Research Center at UCSD (RR00827) and the NIH/NCMHD EXPORT minority health center (MD000220).
PY - 2012/1
Y1 - 2012/1
N2 - Background The cardiometabolic syndrome comprised of multiple correlated traits, but its origin is incompletely understood. Chromogranin A (CHGA) is required for formation of the catecholamine secretory pathway in sympathochromaffin cells. In twin pair studies, we found that CHGA traits aggregated with body mass index (BMI), as well as its biochemical determinant leptin.MethodsHere we used the twin method to probe the role of heredity in generating such risk traits, and then investigated the role of risk-trait-associated CHGA promoter genetic variation in transfected chromaffin cells. Trait heritability (h 2) and shared genetic determination among traits (pleiotropy, genetic covariance, P G) were estimated by variance components in twin pairs. Results CHGA, BMI, and leptin each displayed substantial h 2, and the traits also aggregated with several features of the metabolic syndrome (e.g., insulin resistance, blood pressure (BP), hypertension, catecholamines, and C-reactive protein (CRP)). Twin studies demonstrated genetic covariance (pleiotropy, P G) for CHGA, BMI, and leptin with other metabolic traits (insulin resistance, BP, and CRP). We therefore investigated the CHGA locus for mechanisms of codetermination with such metabolic traits. A common functional variant in the human CHGA promoter (G-462A, rs9658634, minor allele frequency ∼21%) was associated with leptin and CRP secretion, as well as BMI, especially in women; marker-on-trait effects on BMI were replicated across twin populations on two continents. In CHGA promoter/luciferase reporter plasmids transfected into chromaffin cells, G-462A alleles differed markedly in reporter expression. The G-462A variant disrupted predicted transcriptional control by a PPARγ/RXRα motif and costimulation by PPARγ/RXRα and their cognate ligands, differentially activated the two alleles. During chromatin immunoprecipitation, endogenous PPARγ bound the motif. Conclusion sMultiple features of the metabolic syndrome are thus under joint (pleiotropic) genetic determination, with CHGA as one such contributory locus a common polymorphism in the promoter (G-462A) of CHGA predicts such heritable metabolic traits as BMI and leptin. CHGA promoter variant G-462A was not only associated with such metabolic traits but also disrupted a PPARγ/RXRα motif and responded differentially to characteristic trans-activators of that motif. The Results suggest novel links between the catecholaminergic system and risk for the metabolic syndrome as well as systemic hypertension.
AB - Background The cardiometabolic syndrome comprised of multiple correlated traits, but its origin is incompletely understood. Chromogranin A (CHGA) is required for formation of the catecholamine secretory pathway in sympathochromaffin cells. In twin pair studies, we found that CHGA traits aggregated with body mass index (BMI), as well as its biochemical determinant leptin.MethodsHere we used the twin method to probe the role of heredity in generating such risk traits, and then investigated the role of risk-trait-associated CHGA promoter genetic variation in transfected chromaffin cells. Trait heritability (h 2) and shared genetic determination among traits (pleiotropy, genetic covariance, P G) were estimated by variance components in twin pairs. Results CHGA, BMI, and leptin each displayed substantial h 2, and the traits also aggregated with several features of the metabolic syndrome (e.g., insulin resistance, blood pressure (BP), hypertension, catecholamines, and C-reactive protein (CRP)). Twin studies demonstrated genetic covariance (pleiotropy, P G) for CHGA, BMI, and leptin with other metabolic traits (insulin resistance, BP, and CRP). We therefore investigated the CHGA locus for mechanisms of codetermination with such metabolic traits. A common functional variant in the human CHGA promoter (G-462A, rs9658634, minor allele frequency ∼21%) was associated with leptin and CRP secretion, as well as BMI, especially in women; marker-on-trait effects on BMI were replicated across twin populations on two continents. In CHGA promoter/luciferase reporter plasmids transfected into chromaffin cells, G-462A alleles differed markedly in reporter expression. The G-462A variant disrupted predicted transcriptional control by a PPARγ/RXRα motif and costimulation by PPARγ/RXRα and their cognate ligands, differentially activated the two alleles. During chromatin immunoprecipitation, endogenous PPARγ bound the motif. Conclusion sMultiple features of the metabolic syndrome are thus under joint (pleiotropic) genetic determination, with CHGA as one such contributory locus a common polymorphism in the promoter (G-462A) of CHGA predicts such heritable metabolic traits as BMI and leptin. CHGA promoter variant G-462A was not only associated with such metabolic traits but also disrupted a PPARγ/RXRα motif and responded differentially to characteristic trans-activators of that motif. The Results suggest novel links between the catecholaminergic system and risk for the metabolic syndrome as well as systemic hypertension.
KW - BMI
KW - C-reactive protein
KW - adrenal
KW - blood pressure
KW - catecholamine
KW - chromaffin
KW - chromogranin
KW - hypertension
KW - leptin
KW - metabolic syndrome
KW - twin study
UR - http://www.scopus.com/inward/record.url?scp=83655191979&partnerID=8YFLogxK
U2 - 10.1038/ajh.2011.163
DO - 10.1038/ajh.2011.163
M3 - Article
C2 - 21918574
AN - SCOPUS:83655191979
SN - 0895-7061
VL - 25
SP - 29
EP - 40
JO - American Journal of Hypertension
JF - American Journal of Hypertension
IS - 1
ER -